Literature DB >> 2981768

Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.

F M Gotch, C Kelly, S A Ellis, L Wallace, A B Rickinson, J van der Poel, M J Crumpton, A J McMichael.   

Abstract

Five blood donors were identified whose HLA-A2 is different from the common HLA-A2. Their A2 molecule (A2.2) had a more basic isoelectric point than normal A2 (A2.1). Cytotoxic T lymphocytes (CTL) restricted by HLA-A2.1, specific for influenza A and Epstein-Barr viruses, failed to lyse virus-infected target cells with HLA-A2.2. Identical patterns were obtained with both viruses. CTL from four of the A2.2-positive donors recognized target cells prepared from others in the group that shared only the HLA-A2.2 antigen. The A2.2 antigen from one donor seemed to be different in that target cells were not recognized by CTL from donors with the normal A2.1 nor with basic A2.2. There seems, therefore, to be heterogeneity within the HLA-A2.2 subtype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981768     DOI: 10.1007/bf00372237

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 2.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Influenza virus infection of mouse lymphoblasts alters the binding affinity of anti-H-2 antibody: requirement for viral neuraminidase.

Authors:  P A Liberti; C J Hackett; B A Askonas
Journal:  Eur J Immunol       Date:  1979-10       Impact factor: 5.532

4.  Diversity in the interaction of influenza-A-specific cytotoxic T cells with H-2Kb mutant targets.

Authors:  A R Townsend; P M Taylor; C J Melief; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1.

Authors:  M S Krangel; S Taketani; W E Biddison; D M Strong; J L Strominger
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

Review 6.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

7.  Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.

Authors:  W E Biddison; M S Krangel; J L Strominger; F E Ward; G M Shearer; S Shaw
Journal:  Hum Immunol       Date:  1980-10       Impact factor: 2.850

8.  Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells.

Authors:  W E Biddison; S Shaw
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

9.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus.

Authors:  S Shaw; W E Biddison
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  16 in total

1.  An Oriental HLA-A2 subtype is closely related to a subset of Caucasoid HLA-A2 alleles.

Authors:  H Epstein; L J Kennedy; N Holmes
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Molecular analysis of HLA-A2.4 functional variant KLO: close structural and evolutionary relatedness to the HLA-A2.2 subtype.

Authors:  N Doménech; R Castaño; E Goulmy; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.

Authors:  N Doménech; A Ezquerra; R Castaño; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.

Authors:  A J McMichael; F M Gotch; J Santos-Aguado; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Identification of HLA-B44 subtypes associated with extended MHC haplotypes.

Authors:  M S Kruskall; E E Eynon; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1.

Authors:  D H Mattson; D E Handy; D A Bradley; J E Coligan; E P Cowan; W E Biddison
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes.

Authors:  L J Kennedy; L E Wallace; J A Madrigal; A B Rickinson; J G Bodmer
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  The immunological detection of a 21-OH deficiency mutation HLA supratype.

Authors:  M S Pollack; B Keenan; F T Christiansen; T J Cobain; R L Dawkins; G Clayton
Journal:  Am J Hum Genet       Date:  1986-05       Impact factor: 11.025

9.  Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients.

Authors:  P J Hall; S J Burman; M R Laurent; D C Briggs; H E Venning; A M Leak; P A Bedford; B M Ansell
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

10.  An HLA-A2 population variant with structural polymorphism in the alpha 3 region.

Authors:  R Castaño; A Ezquerra; N Doménech; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.